retatrutide trial data phase 2 results Shows Promising in Type Diabetes and Obesity retatrutide trial data New Phase

Initiation and Dose Titration GLP-1 receptor agonists should be initiated at the lowest available dose, with gradual titration over several weeks to months

And keep an eye on ones that are not yet recruiting, as you may be a candidate for them in the future

Figure 1 Exposure to cagrilintide failed to reduce body weight or fat mass in diet-induced obese (DIO) mice

Most importantly, PT-141 does not significantly influence melanin production

Similar results were reported by Wang et al., where GLP-1 RA treatment had a notable impact on the abundance of weight-related microbial phylotypes, though no significant change in the Firmicutes/Bacteroidetes ratio was observed (72)